查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗血栓藥市場趨勢·分析·預測 (2023-2032年):藥物類型 (抗凝固藥·抗血小板藥·血栓溶解藥)·給藥途徑·用途·終端用戶·各地區
市場調查報告書
商品編碼
1259867

抗血栓藥市場趨勢·分析·預測 (2023-2032年):藥物類型 (抗凝固藥·抗血小板藥·血栓溶解藥)·給藥途徑·用途·終端用戶·各地區

Antithrombotic Drugs Market By Drug Type (Anticoagulant Drug, Antiplatelet Drug, Thrombolytic Drug); By Route of Administration, By Application, By End User, and Geography - Trend, Analysis, and Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球抗血栓藥的市場規模到2032年前將成長到1,053億3,000萬美元的規模。

本報告提供全球抗血栓藥的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球抗血栓藥市場洞察

  • 產業概要
  • 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • PESTEL分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19:影響分析

第5章 全球抗血栓藥市場:各藥物類型

  • 主要調查結果
  • 抗凝固藥
  • 抗血小板藥
  • 血栓溶解藥

第6章 全球抗血栓藥市場:各給藥途徑

  • 主要調查結果
  • 口服
  • 非口服

第7章 全球抗血栓藥市場:各用途

  • 主要調查結果
  • 肺動脈栓塞
  • 深部靜脈血栓症
  • 心房顫動
  • 其他

第8章 全球抗血栓藥市場:各終端用戶

  • 主要調查結果
  • 醫院
  • 急救服務
  • 中心
  • 門診病人手術中心
  • 其他

第9章 全球抗血栓藥市場:各地區

  • 主要調查結果
  • 北美
  • 歐洲
  • 亞太地區
  • 中東及非洲
  • 南美

第10章 競爭情形

  • 擴張·收購的分析
  • 聯盟/合作/協定/展示會

第11章 企業簡介

  • Daiichi Sankyo Company
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG
  • Pfizer
  • AstraZeneca plc
  • Johnson & Johnson
  • AstraZeneca
  • Otsuka Pharmaceutical
  • Portola Pharmaceutical Inc
  • Yuyu Pharma Inc., Limited
  • Glenmark Pharmaceuticals Limited
  • China National Pharmaceutical Group Corp
  • Novartis
  • Acetlion Pharmaceuticals
  • Generium Holdings
Product Code: PM1129

The antithrombotic drugs market size is predicted to reach USD 105.33 billion by 2032, in accordance with a new study by Polaris Market Research. The report "Antithrombotic Drugs Market By Drug Type (Anticoagulant Drug, Antiplatelet Drug, Thrombolytic Drug); By Route of Administration, By Application, By End User, and Geography - Trend, Analysis, and Forecast, 2023-2032" gives a complete foresight into current market dynamics and contribute analysis on future market growth.

Rising cardiovascular disease incidence is anticipated to fuel market expansion over the forecast period. Some of the key factors propelling the growth of the worldwide antiplatelet medicines market are the rising prevalence of cardiovascular illnesses, an aging population, and a sedentary lifestyle. In both developed and developing economies, cardiovascular illnesses constitute the main cause of death.

For instance, according to data from the American Heart Association, at least 3 to 6 million persons in the United States alone had atrial fibrillation in June 2018, and the figure is expected to rise to 6 to 16 million by the year 2050. 3,658 heart transplants were carried out in the United States in 2020. The states of California (496), Texas (302), Florida (288), and New York performed the most heart transplants (250).

The antiplatelet market is influenced by things including the widespread use of antithrombotic/anticoagulant medications, an increase in thrombotic occurrences, an aging population, and recent pharmaceutical advancements.

The market for antithrombotic/anticoagulant medications is anticipated to expand rapidly throughout the forecast period due to factors including the increased availability of these medications and the prevalence of chronic thrombotic diseases that necessitate long-term medication use.

The market for antithrombotic medications is expected to be significantly impacted by COVID-19 infection due to the quick pace of research. According to a study published in the American Journal of Cardiovascular Drugs in 2020, there are currently more than ten clinical trials evaluating the efficacy of antithrombotic medications in COVID-19 patients. Additionally, research is being done on parenteral administration techniques for these medications for using critically ill COVID-19 patients.

Antithrombotic Drugs Market Report Highlights:

Antiplatelet drugs are expected to dominate the market due to increasing use for clotting as arterial clots comprised primarily of platelets, antiplatelet medications are most effective.

Activities by key players in the market for the development of antiplatelet drugs are expected to drive the market growth over the forecast period.

Anticoagulant, Thrombolytic, and oral drugs is expected to hold the largest market share during the forecast period. Anticoagulants work by interfering with several blood coagulation pathways, making them closely connected to antiplatelet medications and thrombolytic therapies.

Some of the key players operating in the market include Daiichi Sankyo Company, Eli Lilly and Company, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG, Pfizer, AstraZeneca plc, Johnson & Johnson. AstraZeneca, Otsuka Pharmaceutical, Portola Pharmaceutical Inc., Yuyu Pharma Inc., Limited, Glenmark Pharmaceuticals Limited, China National Pharmaceutical Group Corp, Novartis, Acetlion Pharmaceuticals, Generium Holdings among the others.

Polaris Market Research has segmented the Antithrombotic Drugs market report based on drug type, route of administration, application, end-user and region:

Antithrombotic Drugs market, By Drug Type (Revenue - USD Billion, 2019-2032)

  • Antiplatelet Drug
  • Anticoagulant Drug
  • Thrombolytic Drug

Antithrombotic Drugs market, By Route of Administration (Revenue - USD Billion, 2019-2032)

  • Oral
  • Parenteral

Antithrombotic Drugs market, By Application (Revenue - USD Billion, 2019-2032)

  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Atrial Fibrillation
  • Others

Antithrombotic Drugs market, By End User (Revenue - USD Billion, 2019-2032)

  • Hospitals
  • Ambulatory Surgery Centres
  • Emergency Service Centres
  • Others

Antithrombotic Drugs market, Geography (Revenue - USD Billion, 2019-2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antithrombotic Drugs Market Insights

  • 4.1. Antithrombotic Drugs - Industry Snapshot
  • 4.2. Antithrombotic Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of chronic diseases
      • 4.2.1.2. Rising number geriatric population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects linked with antithrombotic drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Antithrombotic Drugs Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antithrombotic Drugs Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Anticoagulant Drug
    • 5.3.1. Global Antithrombotic Drugs Market, by Anticoagulant Drug, by Region, 2019-2032 (USD Billion)
  • 5.4. Antiplatelet Drug
    • 5.4.1. Global Antithrombotic Drugs Market, by Antiplatelet Drug, by Region, 2019-2032 (USD Billion)
  • 5.5. Thrombolytic Drug
    • 5.5.1. Global Antithrombotic Drugs Market, by Thrombolytic Drug, by Region, 2019-2032 (USD Billion)

6. Global Antithrombotic Drugs Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Antithrombotic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Antithrombotic Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)

7. Global Antithrombotic Drugs Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Pulmonary Embolism
    • 7.3.1. Global Antithrombotic Drugs Market, by Pulmonary Embolism, by Region, 2019-2032 (USD Billion)
  • 7.4. Deep Vein Thrombosis
    • 7.4.1. Global Antithrombotic Drugs Market, by Deep Vein Thrombosis, by Region, 2019-2032 (USD Billion)
  • 7.5. Atrial Fibrillation
    • 7.5.1. Global Antithrombotic Drugs Market, by Atrial Fibrillation, by Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Antithrombotic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Antithrombotic Drugs Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Antithrombotic Drugs Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Emergency Service
    • 8.4.1. Global Antithrombotic Drugs Market, by Emergency Service, by Region, 2019-2032 (USD Billion)
  • 8.5. Centres
    • 8.5.1. Global Antithrombotic Drugs Market, by Centres, by Region, 2019-2032 (USD Billion)
  • 8.6. Ambulatory Surgery Centres
    • 8.6.1. Global Antithrombotic Drugs Market, by Ambulatory Surgery Centres, by Region, 2019-2032 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Antithrombotic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Antithrombotic Drugs Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Antithrombotic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Antithrombotic Drugs Market - North America
    • 9.3.1. North America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.3.2. North America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
    • 9.3.3. North America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.4. North America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.3.5. Antithrombotic Drugs Market - U.S.
      • 9.3.5.1. U.S.: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.3.6. Antithrombotic Drugs Market - Canada
      • 9.3.6.1. Canada: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • 9.4. Antithrombotic Drugs Market - Europe
    • 9.4.1. Europe: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.5. Antithrombotic Drugs Market - UK
      • 9.4.5.1. UK: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.6. Antithrombotic Drugs Market - France
      • 9.4.6.1. France: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.7. Antithrombotic Drugs Market - Germany
      • 9.4.7.1. Germany: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.8. Antithrombotic Drugs Market - Italy
      • 9.4.8.1. Italy: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.9. Antithrombotic Drugs Market - Spain
      • 9.4.9.1. Spain: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.10. Antithrombotic Drugs Market - Netherlands
      • 9.4.10.1. Netherlands: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.4.11. Antithrombotic Drugs Market - Russia
      • 9.4.11.1. Russia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • 9.5. Antithrombotic Drugs Market - Asia Pacific
    • 9.5.1. Asia Pacific: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.5. Antithrombotic Drugs Market - China
      • 9.5.5.1. China: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.6. Antithrombotic Drugs Market - India
      • 9.5.6.1. India: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.7. Antithrombotic Drugs Market - Japan
      • 9.5.7.1. Japan: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.8. Antithrombotic Drugs Market - Malaysia
      • 9.5.8.1. Malaysia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.9. Antithrombotic Drugs Market - Indonesia
      • 9.5.9.1. Indonesia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.5.10. Antithrombotic Drugs Market - South Korea
      • 9.5.10.1. South Korea: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • 9.6. Antithrombotic Drugs Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.6.5. Antithrombotic Drugs Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.6.6. Antithrombotic Drugs Market - South Africa
      • 9.6.6.1. South Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.6.7. Antithrombotic Drugs Market - Israel
      • 9.6.7.1. Israel: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.6.8. Antithrombotic Drugs Market - UAE
      • 9.6.8.1. UAE: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • 9.7. Antithrombotic Drugs Market - Latin America
    • 9.7.1. Latin America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.7.5. Antithrombotic Drugs Market - Mexico
      • 9.7.5.1. Mexico: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.7.6. Antithrombotic Drugs Market - Brazil
      • 9.7.6.1. Brazil: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
    • 9.7.7. Antithrombotic Drugs Market - Argentina
      • 9.7.7.1. Argentina: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Daiichi Sankyo Company
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Eli Lilly and Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bristol-Myers Squibb Company
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. C.H. Boehringer Sohn AG & Ko. KG and Aspen Bayer AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Pfizer
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. AstraZeneca plc
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Johnson & Johnson
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Otsuka Pharmaceutical
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Portola Pharmaceutical Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Yuyu Pharma Inc., Limited
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Glenmark Pharmaceuticals Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. China National Pharmaceutical Group Corp
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Novartis
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Acetlion Pharmaceuticals
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Generium Holdings
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development

List of Tables

  • Table 1 Global Antithrombotic Drugs Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Antithrombotic Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Antithrombotic Drugs Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Antithrombotic Drugs Market, by End User, by Region, 2019-2032 (USD Billion)
  • Table 5 Antithrombotic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 7 North America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 9 North America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 10 U.S.: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 U.S.: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 13 U.S.: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 14 Canada: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 16 Canada: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 17 Canada: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 18 Europe: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 20 Europe: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Europe: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 22 Germany: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 26 France: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 France: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 France: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 29 France: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 30 UK: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 31 UK: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 32 UK: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 33 UK: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 34 Italy: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Italy: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Italy: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 42 Spain: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Spain: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 45 Spain: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 46 Russia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Russia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Russia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 54 China: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 55 China: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 56 China: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 57 China: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 58 Japan: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Japan: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Japan: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 62 India: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 India: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 India: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 65 India: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 74 South Korea: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 76 South Korea: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 77 South Korea: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 78 Latin America: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 80 Latin America: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Latin America: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 82 Brazil: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Brazil: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Brazil: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 86 Mexico: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Mexico: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Mexico: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 90 Argentina: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 92 Argentina: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 93 Argentina: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 98 UAE: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 100 UAE: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 101 UAE: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 106 South Africa: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 South Africa: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 109 South Africa: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)
  • Table 110 Israel: Antithrombotic Drugs Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Antithrombotic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 112 Israel: Antithrombotic Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 113 Israel: Antithrombotic Drugs Market, by End User, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Antithrombotic Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Antithrombotic Drugs Market, by Drug Type, 2019 & 2032 (USD Billion)
  • Figure 8. Market by End User
  • Figure 9. Global Antithrombotic Drugs Market, by End User, 2019 & 2032 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Antithrombotic Drugs Market, by Route of Administration, 2019 & 2032 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Antithrombotic Drugs Market, by Application, 2019 & 2032 (USD Billion)